Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock
-
Number of holders
-
8
-
Total shares
-
74.1K
-
Shares change
-
-4.35M
-
Total reported value, excl. options
-
$26.1K
-
Value change
-
-$1.58M
-
Number of buys
-
2
-
Number of sells
-
-26
-
Price
-
$0.36
Significant Holders of SORRENTO THERAPEUTICS INC - Common Stock (SRNE) as of Q2 2023
8 filings reported holding SRNE - SORRENTO THERAPEUTICS INC - Common Stock as of Q2 2023.
SORRENTO THERAPEUTICS INC - Common Stock (SRNE) has 8 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 74.1K shares
.
Largest 10 shareholders include SlateStone Wealth, LLC (30.9K shares), KLCM Advisors, Inc. (20K shares), HUNTINGTON NATIONAL BANK (16K shares), OGOREK ANTHONY JOSEPH /NY/ /ADV (3.6K shares), AlphaMark Advisors, LLC (3.14K shares), Russell Investments Group, Ltd. (266 shares), TRUST CO OF VERMONT (204 shares), CONCOURSE FINANCIAL GROUP SECURITIES, INC. (25 shares), Tower Research Capital LLC (TRC) (0 shares), and Modus Advisors, LLC (0 shares).
This table shows the top 8 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.